Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc.
Inmune Bio, Inc.
Inmune Bio, Inc.
TVAX Biomedical
National Cancer Institute, Naples
Takeda
Dana-Farber Cancer Institute
Neurologix, Inc.